✦ LIBER ✦

Imatinib bij GIST

Publisher: Prelum Uitgevers
Year: 2003
Weight: 54 KB
Volume: 41
Category: Article
ISSN: 0168-7670
DOI: 10.1007/bf03058226

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gastrointestinal stromal tumor (GIST) an

Gastrointestinal stromal tumor (GIST) and imatinib

✍ Tetsuro Kubota 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 264 KB

Dauertherapie mit dem Tyrosinkinaseinhib

Dauertherapie mit dem Tyrosinkinaseinhibitor Imatinib bei Patienten mit fortgeschrittenem GIST

✍ K. Oechsle; C. Bokemeyer 📂 Article 📅 2007 🏛 Springer 🌐 German ⚖ 119 KB

Recurrent rectal GIST resected successfu

Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate

✍ Madoka Hamada; Kazuhide Ozaki; Tadashi Horimi; Akihito Tsuji; Yoshitsugu Nasu; J 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 405 KB

Pathologic complete response with neoadj

Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST

✍ Carla Rameri Alexandre Silva de Azevedo; Tadeu Ferreira Paiva; Benedito Mauro Ro 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 235 KB

Imatinib (Glivec™) et gist: ne jamais s’

Imatinib (Glivec™) et gist: ne jamais s’arrêter en si bon chemin…

✍ Pascal Artru; Gérard Lledo 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 French ⚖ 80 KB

Myelodysplastic syndrome appearing durin

Myelodysplastic syndrome appearing during imatinib mesylate therapy in a patient with GIST

✍ Vincenzo Pitini; Carmela Arrigo; Maria Grazia Sauta; Giuseppe Altavilla 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 924 KB

The introduction of imatinib has been a major advance in the treatment of gastrointestinal stromal tumor (GIST). However, despite its remarkable efficacy and toxicity profile little is known about the potential for long-term toxicity. This may be an important issue because some patients (pts) with c